Hepatitis B Virus NAT Positive Donors in Non‐Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor‐Derived Infection

Documents similaires

• Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network
  par: Sara Belga, et autres
  Publié: (2025)
• Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
  par: Madeleine R. Heldman, et autres
  Publié: (2024)
• Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
  par: Cathrine M. Moeller, et autres
  Publié: (2024)
• Transmission of Ehrlichia chaffeensis From an Organ Donor to a Kidney–Pancreas Transplant Recipient
  par: Praveen Gundelly, et autres
  Publié: (2025)
• Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients
  par: Chia‐Yu Chiu, et autres
  Publié: (2024)